Literature DB >> 1908853

Antibiotic GE2270 a: a novel inhibitor of bacterial protein synthesis. I. Isolation and characterization.

E Selva1, G Beretta, N Montanini, G S Saddler, L Gastaldo, P Ferrari, R Lorenzetti, P Landini, F Ripamonti, B P Goldstein.   

Abstract

A novel antibiotic, GE2270 A, was isolated from the fermentation broth of a strain of Planobispora rosea. The product was found to inhibit bacterial protein synthesis. Structural characteristics showed similarities between GE2270 A and thiazolyl peptides such as micrococcin which is known to inhibit protein synthesis by acting directly on the ribosome. Despite this similarity GE2270 A showed functional analogy to kirromycin-like antibiotics and pulvomycin, as its molecular target was found to be elongation factor Tu (EF-Tu). GE2270 A is active against Gram-positive microorganism and anaerobes and differs from the other EF-Tu inhibitors in its spectrum of antimicrobial activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908853     DOI: 10.7164/antibiotics.44.693

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  32 in total

1.  Manipulation of thiocillin variants by prepeptide gene replacement: structure, conformation, and activity of heterocycle substitution mutants.

Authors:  Albert A Bowers; Michael G Acker; Alexander Koglin; Christopher T Walsh
Journal:  J Am Chem Soc       Date:  2010-06-02       Impact factor: 15.419

2.  Mechanism of action of and mechanism of reduced susceptibility to the novel anti-Clostridium difficile compound LFF571.

Authors:  J A Leeds; M Sachdeva; S Mullin; J Dzink-Fox; M J Lamarche
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

3.  Efficacy of LFF571 in a hamster model of Clostridium difficile infection.

Authors:  Anna Trzasko; Jennifer A Leeds; Jens Praestgaard; Matthew J Lamarche; David McKenney
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

4.  Antibiotic production improvement in the rare actinomycete Planobispora rosea by selection of mutants resistant to the aminoglycosides streptomycin and gentamycin and to rifamycin.

Authors:  Fabrizio Beltrametti; Roberta Rossi; Enrico Selva; Flavia Marinelli
Journal:  J Ind Microbiol Biotechnol       Date:  2005-12-06       Impact factor: 3.346

Review 5.  Elfamycins: inhibitors of elongation factor-Tu.

Authors:  Samantha M Prezioso; Nicole E Brown; Joanna B Goldberg
Journal:  Mol Microbiol       Date:  2017-08-09       Impact factor: 3.501

Review 6.  Recent advances in the chemistry and biology of naturally occurring antibiotics.

Authors:  K C Nicolaou; Jason S Chen; David J Edmonds; Anthony A Estrada
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

7.  Inhibition of bacterial protein synthesis by elongation-factor-Tu-binding antibiotics MDL 62,879 and efrotomycin.

Authors:  P Landini; M Bandera; B P Goldstein; F Ripamonti; A Soffientini; K Islam; M Denaro
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

Review 8.  The potential for emerging therapeutic options for Clostridium difficile infection.

Authors:  Harsh Mathur; Mary C Rea; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Gut Microbes       Date:  2014

9.  Archaeal elongation factor 1alpha from Sulfolobus solfataricus interacts with the eubacterial antibiotic GE2270A.

Authors:  Mariorosario Masullo; Piergiuseppe Cantiello; Paolo Arcari
Journal:  Extremophiles       Date:  2004-07-30       Impact factor: 2.395

10.  Two heterologously expressed Planobispora rosea proteins cooperatively induce Streptomyces lividans thiostrepton uptake and storage from the extracellular medium.

Authors:  Anna Giardina; Rosa Alduina; Elvira Gottardi; Valentina Di Caro; Roderich D Süssmuth; Anna M Puglia
Journal:  Microb Cell Fact       Date:  2010-06-09       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.